Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nwabundo Nwankwo

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Case Reports in Oncology|August 2, 2013
Breast osteosarcoma 29 years after radiation therapy for epithelial breast cancerNwabundo Nwankwo, Aram Barbaryan, Alaa M Ali, et al.
Case Reports in Hematology|May 28, 2013
Ibuprofen-induced hemolytic anemiaAram Barbaryan, Chioma Iyinagoro, Nwabundo Nwankwo, et al.
Case Reports in Oncology|March 8, 2013
Left inguinal adenopathy two years after cytoreductive surgery: a rare sign of recurrenceAibek E Mirrakhimov, Nwabundo Nwankwo, Aram Barbaryan, et al.
Investigational New Drugs|July 7, 2012
Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokineticsNwabundo Nwankwo, Zhe Zhang, Ting Wang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Case Reports in Oncology|August 2, 2013
Breast osteosarcoma 29 years after radiation therapy for epithelial breast cancerNwabundo Nwankwo, Aram Barbaryan, Alaa M Ali, et al.
Case Reports in Hematology|May 28, 2013
Ibuprofen-induced hemolytic anemiaAram Barbaryan, Chioma Iyinagoro, Nwabundo Nwankwo, et al.
Case Reports in Oncology|March 8, 2013
Left inguinal adenopathy two years after cytoreductive surgery: a rare sign of recurrenceAibek E Mirrakhimov, Nwabundo Nwankwo, Aram Barbaryan, et al.
Investigational New Drugs|July 7, 2012
Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokineticsNwabundo Nwankwo, Zhe Zhang, Ting Wang, et al.
Pageof 2